Abstract
Adjuvant therapy of differentiated thyroid cancer with radioactive iodine is a standard procedure for the ablation of remnant thyroid tissue following surgery and for the treatment of iodine avid metastases. In most cases fixed activities are administered. Presently there are two dosimetric approaches for the treatment of thyroid cancer using radioiodine: a) the 2 Gy bone marrow dose limited approach and b) the optimization of the absorbed dose to iodine avid lesions. Both concepts and their clinical applications and, in addition, new dosimetric methods which include radiobiological considerations are described.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
